Advancell Efficacy

Published: 26-Mar-2010
Regulatory

ADVANCELL in vitro systems are of special value to support marketing claims of efficacy and to provide insights into molecular mechanisms at an early stage.

ADVANCELL in vitro systems are of special value to support marketing claims of efficacy and to provide insights into molecular mechanisms at an early stage in the development process, prior to in vivo assessment in human volunteers and as an alternative to animals. Efficacy Claims: anti-aging, anti-oxidant effect, skin inflammation, skin sensitization, vitalizing, firmness, elasticity, moisturizing, skin repair, photoprotection, calmin effect, reconstituted 3D Human tissues, anti-cellulitic activity, in vivo determination in human volunteers.
See more

You may also like

Manufacturing

Advancell and Gentronix to offer genotoxicity screening assays for C&T industry

Read more
New partnership offers GreenScreen HC and BlueScreen HC via contract service

Trending Articles

  1. Anton Paar expands litesizer portfolio with cost-effective DLS 301 for routine analysis Anton Paar has announced the launch of the Litesizer DLS 301, the latest addition to its established Litesizer family. Designed as a budget-friendly solution for routine analysis, the new instrument provides reliable performance for laboratories working with simpler samples and straightforward quality control workflows
  2. Meet the speakers: 2026 Anti-Ageing Skin Care Conference full agenda revealed Featuring speakers from leading companies such as Unilever, A*STAR Skin Research Lab, Procter & Gamble and others, the biennial Anti-Ageing Skin Care Conference returns with another exciting year of thought leaders who are driving innovation in the skin-care and science industry
  3. Italy launches probe into Procter & Gamble over ‘misleading’ advertising Italy’s competition authority, Autorità Garante della Concorrenza e del Mercato (AGCM), has launched an investigation into the company’s adverts for a Braun hair removal device which it says may have misled consumers
  4. Olalla Consulting Olalla Consulting LTD is a specialist consultancy bridging regulatory excellence, scientific formulation, and strategic brand development for beauty, skincare, and healthcare companies across the UK, EU, and global markets. With more than 20 years of experience leading highimpact projects for topselling brands, the consultancy delivers auditready documentation, compliant innovation, and technical clarity for companies scaling responsibly. Operating from Leeds and Barcelona, Olalla Consulting combines deep scientific expertise with luxurybrand sensibility, supporting founders, suppliers, and established corporations with transparent processes, rigorous compliance, and futurefocused product strategy
  5. Estée Lauder Companies fined $750,000 over environmental law violations The beauty company pleads guilty to two violations of environmental laws in Canada, related to ‘forever chemicals’

Upcoming event

Sustainability & Green Chemistry: From Claims to Credible Impact

26 February and 5 March 2026 | Virtual See all

You may also like

Manufacturing

Advancell and Gentronix to offer genotoxicity screening assays for C&T industry

New partnership offers GreenScreen HC and BlueScreen HC via contract service
Regulatory

Scientific Advisor

Based on its large expertise in cell culture, molecular biology, toxicity and efficacy studies.
Regulatory

Advancell Irritation & Corrosion Testing

ADVANCELL offers in vitro safety and toxicology services in accordance to OECD Guidelines and ECVAM test procedures.
Regulatory

Advancell Toxicity

ADVANCELL offers in vitro safety and toxicology services in accordance to OECD Guidelines and ECVAM test procedures.
Regulatory

Neutrogena owner agrees $4.7 million settlement over Skin360 biometric data privacy claims

Johnson & Johnson Consumer, which is now known as Kenvue, has agreed to a settlement in a class action lawsuit, in which it was alleged that the skin care brand’s facial scanning technology collected and stored data without users’ consent
Regulatory

Anton Paar expands litesizer portfolio with cost-effective DLS 301 for routine analysis

Anton Paar has announced the launch of the Litesizer DLS 301, the latest addition to its established Litesizer family. Designed as a budget-friendly solution for routine analysis, the new instrument provides reliable performance for laboratories working with simpler samples and straightforward quality control workflows
Regulatory

Italy launches probe into Procter & Gamble over ‘misleading’ advertising

Italy’s competition authority, Autorità Garante della Concorrenza e del Mercato (AGCM), has launched an investigation into the company’s adverts for a Braun hair removal device which it says may have misled consumers
Subscribe now